Top Suppliers:I want be here


31431-43-3

31431-43-3 structure
31431-43-3 structure

Name methyl N-[6-(cyclopropanecarbonyl)-1H-benzimidazol-2-yl]carbamate
Synonyms Ciclobendazol [INN-Spanish]
Cyclobendazole
Cyclobendazole (Methyl [5-(cyclopropylcarbonyl)-1H-benzimidazol-2-yl]carbamate
methyl 5-cyclopropylcarbonyl-1H-benzimidazol-2-ylcarbamate
Ciclobendazolum [INN-Latin]
(5-cyclopropanecarbonyl-1(3)H-benzoimidazol-2-yl)-carbamic acid methyl ester
Methyl-N-<5(6)-(cyclopropylcarbonyl)-2-benzimidazolyl>-carbamat
Ciclobendazole
EINECS 250-637-5
R 17,147
5-Cyclopropylcarbonylcarbendazime
Density 1.478g/cm3
Boiling Point 402.52°C (rough estimate)
Melting Point 250.5°
Molecular Formula C13H13N3O3
Molecular Weight 259.26100
Exact Mass 259.09600
PSA 84.08000
LogP 2.40690
Index of Refraction 1.728

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DD6497000
CHEMICAL NAME :
2-Benzimidazolecarbamic acid, 5-(cyclopropylcarbonyl)-, methyl ester
CAS REGISTRY NUMBER :
31431-43-3
LAST UPDATED :
199612
DATA ITEMS CITED :
5
MOLECULAR FORMULA :
C13-H13-N3-O3
MOLECULAR WEIGHT :
259.29
WISWESSER LINE NOTATION :
T56 BM DNJ CMVO1 GV- AL3TJ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
104 mg/kg
SEX/DURATION :
female 8-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
104 mg/kg
SEX/DURATION :
female 8-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
68800 ug/kg
SEX/DURATION :
female 8-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death

MUTATION DATA

TYPE OF TEST :
Mutation test systems - not otherwise specified
TEST SYSTEM :
Human Cells - not otherwise specified
DOSE/DURATION :
2 mg/L
REFERENCE :
THERAP Therapie. (Doin, Editeurs, 8, Place de l'Odeon, F-75006 Paris, France) V.1- 1946- Volume(issue)/page/year: 31,505,1976
Symbol GHS07
GHS07
Signal Word Warning
Hazard Statements H317
Precautionary Statements P280
Hazard Codes Xi
Risk Phrases 43
Safety Phrases 36/37
RIDADR NONH for all modes of transport
HS Code 2933990090
HS Code 2933990090
Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%